tcell
reactiv
analyz
recent
year
ago
smallpox
vaccin
longterm
vaccin
year
ago
vaccin
person
briefli
peripher
blood
mononuclear
cell
pbmc
isol
standard
densiti
centrifug
ficollhypaqu
pharmacia
uppsala
sweden
stimul
also
perform
whole
blood
sampl
howev
assay
reduc
sensit
exclud
possibl
whole
bloodassay
sensit
could
improv
chang
protocol
condit
data
shown
pbmc
cultur
complet
roswel
park
memori
institut
medium
vv
heatinactiv
fetal
calf
serum
mm
lglutamin
uml
penicillinstreptomycin
concentr
cellsml
stimul
perform
total
protein
content
approxim
vaccinia
viral
antigen
resuspend
accord
manufactur
instruct
main
biotechnolog
servic
portland
cmv
antigen
biowhittak
walkersvil
md
alway
presenc
costimul
monoclon
antibodi
becton
dickinson
compani
franklin
lake
nj
also
test
tcell
respons
live
vacciniainfect
fibroblast
vero
cell
respons
uninfect
antigen
prepar
alway
background
reduc
sensit
assay
data
shown
therefor
commerci
avail
antigen
use
subsequ
experi
cultur
incub
h
follow
addit
overnight
incub
secret
inhibitor
brefeldina
sigmaaldrich
corpor
st
loui
mo
cell
wash
twice
phosphatebuff
salin
bovin
serum
albumin
sodium
azid
stain
min
monoclon
antibodi
specif
cell
surfac
cd
antigen
becton
dickinson
compani
sampl
fix
paraformaldehyd
min
incub
phycoerithrinconjug
mouseantihuman
becton
dickinson
compani
wash
twice
phosphatebuff
salin
bovin
serum
albumin
saponin
resuspend
facsflow
acquir
facscalibur
becton
dickinson
compani
previous
describ
control
nonspecif
stain
monitor
isotypematch
monoclon
antibodi
becton
dickinson
compani
cell
incub
includ
experi
nonspecif
stain
alway
subtract
specif
result
cytometr
panel
shown
figur
product
cell
log
lower
intens
compar
antigenspecif
tcell
respons
repres
unspecif
respons
may
involv
natur
killer
cell
monitor
antigenspecif
tcell
respons
collect
data
cell
produc
higher
amount
neg
control
antigen
stimul
alway
detect
limit
assay
cytometr
panel
figur
show
synthesi
cell
vitro
stimul
vaccinia
viru
cmv
antigen
shown
panel
e
f
donor
strongli
reactiv
cmv
antigen
cell
respect
number
cmvspecif
cell
per
blood
millilit
respect
previous
describ
cmvspecif
respons
relat
cell
cmvspecif
cell
respect
unvaccin
longterm
vaccin
healthi
donor
undetect
respons
smallpox
vaccinia
antigen
figur
panel
b
contrast
recal
respons
detect
recent
immun
figur
panel
c
case
percentag
cell
specif
smallpox
vaccin
antigen
among
cell
number
vaccinia
antigenspecif
cell
per
blood
ml
correspond
frequenc
vacciniaspecif
cell
detect
assay
vacciniaspecif
cell
vacciniaspecif
cell
nevertheless
sensit
assay
detect
cell
could
improv
use
human
leukocyt
antigen
hla
class
peptid
previous
describ
vigor
longlast
protect
immun
respons
associ
smallpox
vaccin
specif
immun
believ
maintain
decad
longterm
vaccin
person
virusspecif
tlymphocyt
detect
extens
vitro
cultur
restimul
gener
antigenspecif
line
clone
limit
due
long
limit
lifespan
memori
cell
low
frequenc
usual
vitro
rapid
assay
base
shorttim
primari
tcell
respons
unabl
show
residu
memori
tcell
respons
present
longterm
vaccin
person
sinc
assay
sensit
log
lower
could
detect
higher
frequenc
antigenspecif
cell
appear
week
smallpox
vaccin
inocul
accordingli
terajima
et
al
demonstr
tcell
respons
vaccinia
variola
conserv
epitop
peak
day
primari
immun
vaccinia
viru
studi
frequenc
antigenspecif
cell
measur
product
elispot
hlapeptid
method
strong
correl
data
deriv
elispot
tetram
assay
intracellular
cytokin
stain
previous
observ
vacciniaspecif
cell
could
detect
flow
cytometri
day
immun
vaccinia
viru
addit
pincu
flick
demonstr
initi
develop
delay
hypersensit
index
cellmedi
immun
earli
day
smallpox
vaccin
viral
infect
high
level
virusspecif
cell
found
acut
infect
fall
detect
limit
viral
load
decreas
reappear
chronic
infect
episod
transient
viremia
accordingli
observ
frequenc
hivspecif
cell
releas
quantit
increas
week
viral
rebound
consequ
interrupt
antivir
therapi
observ
indic
frequenc
virusspecif
cell
clinic
relev
suggest
method
may
use
detect
immun
respons
monitor
frequenc
virusspecif
cell
recent
vaccin
person
memori
cell
expand
antigen
reexposur
increas
frequenc
could
quantit
detect
rapid
flow
cytometr
tcell
assay
confirm
efficaci
vaccin
moreov
high
similar
orthopoxvirus
rapid
assay
use
vaccinia
antigen
could
use
identifi
recent
expos
person
final
import
aspect
develop
diagnost
assay
use
rapid
easili
autom
system
work
virtual
person
carri
diseas
context
intracellular
tcell
cytokin
stain
flow
cytometri
present
sever
advantag
comparison
techniqu
tetram
stain
elispot
fact
flow
cytometri
allow
test
multipl
protein
peptid
singl
time
provid
time
quantit
phenotyp
assess
respond
cell
moreov
optim
antigen
prepar
peptid
pool
design
virusspecif
highli
conserv
independ
hla
haplotyp
may
allow
develop
second
gener
sensit
flow
cytometr
tcell
assay
extend
possibl
perform
routin
analysi
cryopreserv
sampl
techniqu
could
easili
autom
use
analyt
instrument
alreadi
avail
clinic
laboratori
use
flow
cytometri
comparison
analyt
system
assess
antigenspecif
respons
method
econom
advantag
recent
avail
mobil
flowcytomet
unit
may
allow
use
assay
field
investig
condit
